MedTrace Logo

Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne

NCT02338544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1388

Last updated 2016-02-17

No results posted yet for this study

Summary

The purpose of this observational trial is to assess application and convenience of Epiduo® PUMP under daily clinical practice conditions in patients with moderate to severe inflammatory acne.

Conditions

  • Acne Vulgaris

Interventions

DRUG

0.1% Adapalene / 2.5% Benzoyl peroxide

Epiduo® gel containing 0.1% adapalene + 2.5% benzoyl peroxide dispensed from a pump.

Sponsors & Collaborators

  • Galderma Laboratorium GmbH

    lead INDUSTRY

Principal Investigators

  • Uwe Gieler, Prof. M.D. · Universitätsklinikum Gießen und Marburg GmbH

Eligibility

Min Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-09-30
Completion
2015-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02338544 on ClinicalTrials.gov